Correspondence on 'Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab'

Ann Rheum Dis. 2023 Jun;82(6):e132. doi: 10.1136/annrheumdis-2021-220382. Epub 2021 May 12.

Authors

Desiree Tampe¹, Peter Korsten¹, Samy Hakroush², Martin Sebastian Winkler³, Björn Tampe⁴

Affiliations

¹ Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
² Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
³ Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany.
⁴ Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany [email protected].

PMID: 33980606
DOI: 10.1136/annrheumdis-2021-220382

No abstract available

Keywords: Covid-19; rituximab; systemic vasculitis.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19* / complications
Granulomatosis with Polyangiitis* / complications
Granulomatosis with Polyangiitis* / drug therapy
Humans
Rituximab / therapeutic use

Substances

Rituximab